F. Braun

Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil

V. Armstrong, E. Schütz, G. Brenner-Weiss, 1999, British journal of pharmacology.

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

U. Kunzendorf, A. Caliebe, I. Cascorbi, 2007, Clinical pharmacology and therapeutics.

Binding sites for atrial natriuretic peptide on platelets in patients with congestive cardiomyopathy

T. Strom, R. Gerzer, K. Stangl, 1988, European journal of clinical investigation.

Increased Mycophenolic Acid Exposure in Stable Kidney Transplant Recipients on Tacrolimus as Compared With Those on Sirolimus: Implications for Pharmacokinetics

V. Armstrong, U. Kunzendorf, L. Renders, 2009, Clinical pharmacology and therapeutics.

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

H. Riess, P. Cockwell, R. Borrows, 2019, Annals of Hematology.

EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients

F. Rauchfuß, H. Schlitt, U. Merle, 2023, Trials.